Read the full stored bill text
LEGISLATURE
OF
THE
STATE
OF
IDAHO
Sixty-eighth
Legislature
Second
Regular
Session
-
2026
IN
THE
HOUSE
OF
REPRESENTATIVES
HOUSE
BILL
NO.
830
BY
STATE
AFFAIRS
COMMITTEE
AN
ACT
1
RELATING
TO
UNIFORM
CONTROLLED
SUBSTANCES;
AMENDING
SECTION
37
-
2705,
IDAHO
2
CODE,
TO
PROVIDE
THAT
ALKALOIDS
FOUND
IN
OR
DERIVED
FROM
MITRAGYNA
3
SPECIOSA
SHALL
BE
A
SCHEDULE
I
CONTROLLED
SUBSTANCE;
AND
DECLARING
AN
4
EMERGENCY
AND
PROVIDING
AN
EFFECTIVE
DATE.
5
Be
It
Enacted
by
the
Legislature
of
the
State
of
Idaho:
6
SECTION
1.
That
Section
37
-
2705,
Idaho
Code,
be,
and
the
same
is
hereby
7
amended
to
read
as
follows:
8
37
-
2705.
SCHEDULE
I.
(a)
The
controlled
substances
listed
in
this
sec
-
9
tion
are
included
in
schedule
I.
10
(b)
Any
of
the
following
opiates,
including
their
isomers,
esters,
1
1
ethers,
salts,
and
salts
of
isomers,
esters,
and
ethers,
unless
specifically
12
excepted,
whenever
the
existence
of
these
isomers,
esters,
ethers
and
salts
13
is
possible
within
the
specific
chemical
designation:
14
(1)
Acetyl
-
alpha
-
methylfentanyl
(N
-
[1
-
(1
-
methyl
-
2
-
phenethyl)
-
4
-
pip
-
15
eridinyl]
-
N
-
phenylacetamide);
16
(2)
Acetylmethadol;
17
(3)
Acetyl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenylac
-
18
etamide);
19
(4)
Acryl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenylacry
-
20
lamide);
21
(5)
Allylprodine;
22
(6)
Alphacetylmethadol
(except
levo
-
alphacetylmethadol
also
known
as
23
levo
-
alpha
-
acetylmethadol,
levomethadyl
acetate
or
LAAM);
24
(7)
Alphameprodine;
25
(8)
Alphamethadol;
26
(9)
Alpha'
-
methyl
butyryl
fentanyl
(2
-
methyl
-
N
-
(1
-
phenethylpiperidi
-
27
n
-
4
-
yl)
-
N
-
phenylbutanamide);
28
(10)
Alpha
-
methylfentanyl;
29
(11)
Alpha
-
methylthiofentanyl
(N
-
[1
-
methyl
-
2
-
(2
-
thienyl)ethyl
-
4
-
30
piperidinyl]
-
N
-
phenylpropanamide);
31
(12)
Benzethidine;
32
(13)
Betacetylmethadol;
33
(14)
Beta
-
hydroxyfentanyl
(N
-
[1
-
(2
-
hydroxy
-
2
-
phenethyl)
-
4
-
piperid
-
34
inyl]
-
N
-
phenylpropanamide);
35
(15)
Beta
-
hydroxythiofentanyl;
36
(16)
Beta
-
hydroxy
-
3
-
methylfentanyl
(N
-
(1
-
(2
-
hydroxy
-
2
-
phenethyl)
-
3
-
37
methyl
-
4
-
piperidinyl)
-
N
-
phenylpropanamide);
38
(17)
Betameprodine;
39
(18)
Betamethadol;
40
(19)
Beta
-
methyl
fentanyl;
41
(20)
Beta'
-
phenyl
fentanyl;
42
2
(21)
Betaprodine;
1
(22)
Brorphine
(1
-
(1
-
(1
-
(4
-
Bromophenyl)ethyl)piperidin
-
4
-
yl)
-
1,3
-
2
dihydro
-
2H
-
benzo[D]imidazol
-
2
-
one);
3
(23)
Butonitazene
(2
-
(2
-
(4
-
butoxybenzyl)
-
5
-
nitro
-
1hbenzimida
-
4
zol
-
1
-
yl)
-
N,N
-
diethylethan
-
1
-
amine);
5
(24)
Clonitazene;
6
(25)
Crotonyl
fentanyl
((E)
-
N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenyl
-
7
but
-
2
-
enamide);
8
(26)
Cyclopentyl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenylcy
-
9
clopentanecarboxamide);
10
(27)
Cyclopropyl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenylcy
-
1
1
clopropanecarboxamide);
12
(28)
Dextromoramide;
13
(29)
Diampromide;
14
(30)
Diethylthiambutene;
15
(31)
Difenoxin;
16
(32)
Dimenoxadol;
17
(33)
Dimepheptanol;
18
(34)
2',5'
-
Dimethoxyfentanyl
(N
-
(1
-
(2,5
-
dimethoxyphenethyl)piperi
-
19
din
-
4
-
yl)
-
N
-
phenylpropionamide);
20
(35)
Dimethylthiambutene;
21
(36)
Dioxaphetyl
butyrate;
22
(37)
Dipipanone;
23
(38)
Ethylmethylthiambutene;
24
(39)
Etodesnitazene;
Etazene
(2
-
(2
-
(4
-
ethoxybenzyl)
-
1hbenzimida
-
25
zol
-
1
-
yl)
-
N,N
-
diethylethan
-
1
-
amine);
26
(40)
Etonitazene;
27
(41)
Etoxeridine;
28
(42)
Fentanyl
-
related
substances.
"Fentanyl
-
related
substances"
29
means
any
substance
not
otherwise
listed
and
for
which
no
exemption
or
30
approval
is
in
effect
under
section
505
of
the
federal
food,
drug,
and
31
cosmetic
act,
21
U.S.C.
355,
and
that
is
structurally
related
to
fen
-
32
tanyl
by
one
(1)
or
more
of
the
following
modifications:
33
i.
Replacement
of
the
phenyl
portion
of
the
phenethyl
group
by
any
34
monocycle,
whether
or
not
further
substituted
in
or
on
the
monocy
-
35
cle;
36
ii.
Substitution
in
or
on
the
phenethyl
group
with
alkyl,
alkenyl,
37
alkoxyl,
hydroxyl,
halo,
haloalkyl,
amino,
or
nitro
groups;
38
iii.
Substitution
in
or
on
the
piperidine
ring
with
alkyl,
39
alkenyl,
alkoxyl,
ester,
ether,
hydroxyl,
halo,
haloalkyl,
amino,
40
or
nitro
groups;
41
iv.
Replacement
of
the
aniline
ring
with
any
aromatic
monocycle,
42
whether
or
not
further
substituted
in
or
on
the
aromatic
monocy
-
43
cle;
and/or
44
v.
Replacement
of
the
N
-
propionyl
group
by
another
acyl
group;
45
(43)
Fentanyl
carabamate;
46
(44)
Flunitazene
(N,N
-
diethyl
-
2
-
(2
-
(4
-
fluorobenzyl)
-
5
-
nitro
-
1h
-
ben
-
47
zimidazol
-
1
-
yl)ethan
-
1
-
amine);
48
(45)
4
-
Fluoroisobutyryl
fentanyl
(N
-
(4
-
fluorophenyl)
-
N
-
(1
-
49
phenethylpiperidin
-
4
-
yl)isobutyramide);
50
3
(46)
2'
-
fluoro
ortho
-
fluorofentanyl;
1
(47)
Furanyl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenylfu
-
2
ran
-
2
-
carboxamide);
3
(48)
3
-
Furanyl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenylfu
-
4
ran
-
3
-
carboxamide);
5
(49)
Furethidine;
6
(50)
Hydroxypethidine;
7
(51)
Isobutyryl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
8
phenylisobutyramide);
9
(52)
Isovalery
fentanyl
(3
-
methyl
-
N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
10
phenylbutanimide);
1
1
(53)
Isotonitazene
(N,N
-
diethyl
-
2
-
(2
-
(4isopropoxybenzyl)
-
5
-
ni
-
12
tro
-
1h
-
benzimidazol
-
1
-
yl)ethan
-
1
-
amine);
13
(54)
Ketobemidone;
14
(55)
Levomoramide;
15
(56)
Levophenacylmorphan;
16
(57)
Meta
-
fluorofentanyl
(N
-
(3
-
fluorophenyl)
-
N
-
(1
-
phenethylpiperi
-
17
din
-
4
-
yl)isobutyramide);
18
(58)
Meta
-
fluoroisobutyryl
fentanyl
(N
-
(3
-
fluorophenyl)
-
N
-
(1
-
19
phenethylpiperidin
-
4
-
yl)isobutyramide);
20
(59)
Methoxyacetyl
fentanyl
(2
-
methoxy
-
N
-
(1
-
phenethylpiperidin
-
4
-
21
yl)
-
N
-
phenylacetamide);
22
(60)
2
-
Methyl
AP
-
237
(1
-
(2
-
methyl
-
4
-
(3
-
phenylprop
-
2
-
en
-
1
-
yl)piper
-
23
azin
-
1
-
yl)butan
-
1
-
one);
24
(61)
4'
-
methyl
acetyl
fentanyl;
25
(62)
3
-
Methylfentanyl;
26
(63)
3
-
methylthiofentanyl
(N
-
[(3
-
methyl
-
1
-
(2
-
thienyl)ethyl
-
4
-
pip
-
27
eridinyl]
-
N
-
phenylpropanamide);
28
(64)
Metodesnitazene
(N,N
-
diethyl
-
2
-
(2
-
(4
-
methoxybenzyl)
-
1h
-
benzim
-
29
idazol
-
1
-
yl)ethan
-
1
-
amine);
30
(65)
Metonitazene
(N,N
-
diethyl
-
2
-
(2
-
(4
-
methoxybenzyl)
-
5
-
nitro
-
31
1hbenzimidazol
-
1
-
yl)ethan
-
1
-
amine);
32
(66)
Morpheridine;
33
(67)
MPPP
(1
-
methyl
-
4
-
phenyl
-
4
-
propionoxypiperidine);
34
(68)
MT
-
45
(1
-
cyclohexyl
-
4
-
(1,2
-
diphenylethyl)piperazine);
35
(69)
N
-
(4
-
chlorophenyl)
-
N
-
(1
-
phenethylpiperdin
-
4
-
yl)Isobutyramide
36
(para
-
chloroisobutyrl
fentanyl);
37
(70)
Noracymethadol;
38
(71)
Norlevorphanol;
39
(72)
Normethadone;
40
(73)
Norpipanone;
41
(74)
N
-
pyrrolidino
etonitazene
(2
-
(4
-
ethoxybenzyl)
-
5
-
nitro
-
1
-
(2
-
42
(pyrrolidin
-
1
-
yl)ethyl)1hbenzimidazole);
43
(75)
Ocfentanil
(N
-
(2
-
fluorophenyl)
-
2
-
methoxy
-
N
-
(1
-
phenethyl
-
44
piperidin
-
4
-
yl)acetamide);
45
(76)
Ortho
-
fluoroacryl
fentanyl;
46
(77)
Ortho
-
fluorobutyrl
fentanyl;
47
(78)
Ortho
-
fluorofentanyl;
48
(79)
Ortho
-
fluorofuranyl
fentanyl
(N
-
(2
-
fluorophenyl)
-
N
-
(1
-
49
phenethylpiperidin
-
4
-
yl)furan
-
2
-
carboxamide);
50
4
(80)
Ortho
-
fluoroisobutyryl
fentanyl;
1
(81)
Ortho
-
methyl
acetylfentanyl;
2
(82)
Ortho
-
methyl
methoxyacetyl
fentanyl;
3
(83)
Para
-
chloroisobutyryl
fentanyl
(N
-
(4
-
chlorophenyl)
-
N
-
(1
-
4
phenethylpiperidin
-
4
-
yl)
isobutyramide);
5
(84)
Para
-
fluorobutyryl
fentanyl
(N
-
(4
-
fluorophenyl)
-
N
-
(1
-
6
phenethylpiperidin
-
4
-
yl)
butyramide);
7
(85)
Para
-
fluorofentanyl
(N
-
(4
-
fluorophenyl)
-
N
-
[1
-
(2
-
phenethyl)
-
4
-
8
piperidinyl]
propanamide);
9
(86)
Para
-
fluoro
furanyl
fentanyl;
10
(87)
Para
-
methoxybutyryl
fentanyl
(N
-
(4
-
methoxyphenyl)
-
N
-
(1
-
1
1
phenethylpiperidin
-
4
-
yl)
butyramide);
12
(88)
Para
-
methoxyfuranyl
fentanyl
(N
-
(4
-
methoxyphenyl)
-
N
-
(1
-
13
phenethylpiperidin
-
4
-
yl)furan
-
2
-
carboxamide);
14
(89)
Para
-
methylcyclopropyl
fentanyl
(N
-
(4
-
methylphenyl)
-
N
-
(1
-
15
phenylpiperidin
-
4
-
yl)cyclopropanecarboxamide);
16
(90)
Para
-
methylfentanyl;
17
(91)
PEPAP
(1
-
(
-
2
-
phenethyl)
-
4
-
phenyl
-
4
-
acetoxypiperidine);
18
(92)
Phenadoxone;
19
(93)
Phenampromide;
20
(94)
Phenomorphan;
21
(95)
Phenoperidine;
22
(96)
Phenyl
fentanyl;
23
(97)
Piritramide;
24
(98)
Proheptazine;
25
(99)
Properidine;
26
(100)
Propiram;
27
(101)
Protonitazene
(N,N
-
diethyl
-
2
-
(5
-
nitro
-
2
-
(4
-
propoxyben
-
28
zyl)
-
1h
-
benzimidazol
-
1
-
yl)ethan
-
1
-
amine);
29
(102)
Racemoramide;
30
(103)
Tetrahydrofuranyl
fentanyl
(N
-
(1
-
phenethylpiperidine
-
4
-
yl)
-
N
-
31
phenyltetrahydrofuran
-
2
-
carboxamide);
32
(104)
Thiofentanyl
(N
-
phenyl
-
N
-
[1
-
(2
-
thienyl)ethyl
-
4
-
piperidinyl]
-
33
propanamide);
34
(105)
Tilidine;
35
(106)
Trimeperidine;
36
(107)
u
-
47700
(3,4
-
Dichloro
-
N
-
[2
-
(dimethylamino)cyclohexyl]
-
N
-
37
methylbenzamide);
38
(108)
Valeryl
fentanyl
(N
-
(1
-
phenethylpiperidin
-
4
-
yl)
-
N
-
phenyl
-
39
pentanamide);
40
(109)
Zipeprol
(1
-
methoxy
-
3
-
[4
-
(2
-
methoxy
-
2
-
phenylethyl)piper
-
41
azin
-
1
-
yl]
-
1
-
phenylpropan
-
2
-
ol).
42
(c)
Any
of
the
following
opium
derivatives,
their
salts,
isomers
and
43
salts
of
isomers,
unless
specifically
excepted,
whenever
the
existence
of
44
these
salts,
isomers
and
salts
of
isomers
is
possible
within
the
specific
45
chemical
designation:
46
(1)
Acetorphine;
47
(2)
Acetyldihydrocodeine;
48
(3)
Benzylmorphine;
49
(4)
Codeine
methylbromide;
50
5
(5)
Codeine
-
N
-
Oxide;
1
(6)
Cyprenorphine;
2
(7)
Desomorphine;
3
(8)
Dihydromorphine;
4
(9)
Drotebanol;
5
(10)
Etorphine
(except
hydrochloride
salt);
6
(11)
Heroin;
7
(12)
Hydromorphinol;
8
(13)
Methyldesorphine;
9
(14)
Methyldihydromorphine;
10
(15)
Morphine
methylbromide;
1
1
(16)
Morphine
methylsulfonate;
12
(17)
Morphine
-
N
-
Oxide;
13
(18)
Myrophine;
14
(19)
Nicocodeine;
15
(20)
Nicomorphine;
16
(21)
Normorphine;
17
(22)
Pholcodine;
18
(23)
Thebacon.
19
(d)
Hallucinogenic
substances.
Any
material,
compound,
mixture
or
20
preparation
that
contains
any
quantity
of
the
following
hallucinogenic
21
substances,
their
salts,
isomers
and
salts
of
isomers,
unless
specifically
22
excepted,
whenever
the
existence
of
these
salts,
isomers,
and
salts
of
iso
-
23
mers
is
possible
within
the
specific
chemical
designation
(for
purposes
of
24
this
subsection
only,
the
term
"isomer"
includes
the
optical,
position
and
25
geometric
isomers):
26
(1)
Dimethoxyphenethylamine,
or
any
compound
not
specifically
27
excepted
or
listed
in
another
schedule
that
can
be
formed
from
28
dimethoxyphenethylamine
by
replacement
of
one
(1)
or
more
hydrogen
29
atoms
with
another
atom(s),
functional
group(s)
or
substructure(s)
30
including,
but
not
limited
to,
compounds
such
as
DOB,
DOC,
2C
-
B,
31
25B
-
NBOMe;
32
(2)
Methoxyamphetamine
or
any
compound
not
specifically
excepted
or
33
listed
in
another
schedule
that
can
be
formed
from
methoxyamphetamine
34
by
replacement
of
one
(1)
or
more
hydrogen
atoms
with
another
atom(s),
35
functional
group(s)
or
substructure(s)
including,
but
not
limited
to,
36
compounds
such
as
PMA
and
DOM;
37
(3)
5
-
methoxy
-
3,4
-
methylenedioxy
-
amphetamine;
38
(4)
5
-
methoxy
-
N,N
-
diisopropyltryptamine;
39
(5)
Amphetamine
or
methamphetamine
with
a
halogen
substitution
on
the
40
benzyl
ring,
including
compounds
such
as
fluorinated
amphetamine
and
41
fluorinated
methamphetamine;
42
(6)
3,4
-
methylenedioxy
amphetamine;
43
(7)
3,4
-
methylenedioxymethamphetamine
(MDMA);
44
(8)
3,4
-
methylenedioxy
-
N
-
ethylamphetamine
(also
known
as
N
-
et
-
45
hyl
-
alpha
-
methyl
-
3,4
(methylenedioxy)
phenethylamine,
and
N
-
et
-
46
hyl
MDA,
MDE,
MDEA);
47
(9)
N
-
hydroxy
-
3,4
-
methylenedioxyamphetamine
(also
known
as
N
-
hyd
-
48
roxy
-
alpha
-
methyl
-
3,4(methylenedioxy)
phenethylamine,
and
N
-
hyd
-
49
roxy
MDA);
50
6
(10)
3,4,5
-
trimethoxy
amphetamine;
1
(11)
5
-
methoxy
-
N,N
-
dimethyltryptamine
(also
known
as
5
-
methoxy
-
3
-
2[2
-
2
(dimethylamino)ethyl]indole
and
5
-
MeO
-
DMT);
3
(12)
Alpha
-
ethyltryptamine
(some
other
names:
etryptamine,
3
-
(2
-
am
-
4
inobutyl)
indole);
5
(13)
Alpha
-
methyltryptamine;
6
(14)
Bufotenine;
7
(15)
Diethyltryptamine
(DET);
8
(16)
Dimethyltryptamine
(DMT);
9
(17)
Ibogaine;
10
(18)
Lysergic
acid
diethylamide;
1
1
(19)
Marihuana;
12
(20)
Mescaline;
13
(21)
Methoxetamine;
14
(22)
Parahexyl;
15
(23)
Peyote;
16
(24)
N
-
ethyl
-
3
-
piperidyl
benzilate;
17
(25)
N
-
methyl
-
3
-
piperidyl
benzilate;
18
(26)
Para
-
methoxymethamphetamine
(PMMA),
1
-
(4
-
methoxyphenyl)
-
N
-
19
methylpropan
-
2
-
amine;
20
(27)
Psilocybin;
21
(28)
Psilocyn;
22
(29)
Tetrahydrocannabinols
or
synthetic
equivalents
of
the
substances
23
contained
in
the
plant,
or
in
the
resinous
extractives
of
Cannabis,
sp.
24
and/or
synthetic
substances,
derivatives,
and
their
isomers
with
simi
-
25
lar
chemical
structure
such
as
the
following:
26
i.
Tetrahydrocannabinols,
except
for
the
permitted
amount
of
27
tetrahydrocannabinol
found
in
industrial
hemp,
or
nabiximols
in
a
28
drug
product
approved
by
the
United
States
food
and
drug
adminis
-
29
tration:
30
a.
∆
1
cis
or
trans
tetrahydrocannabinol,
and
their
opti
-
31
cal
isomers,
excluding
dronabinol
in
sesame
oil
and
encapsu
-
32
lated
in
either
a
soft
gelatin
capsule
or
in
an
oral
solution
33
in
a
drug
product
approved
by
the
U.S.
Food
and
Drug
Adminis
-
34
tration.
35
b.
∆
6
cis
or
trans
tetrahydrocannabinol,
and
their
optical
36
isomers.
37
c.
∆
3
,
4
cis
or
trans
tetrahydrocannabinol,
and
its
optical
38
isomers.
(Since
nomenclature
of
these
substances
is
not
in
-
39
ternationally
standardized,
compounds
of
these
structures,
40
regardless
of
numerical
designation
of
atomic
positions
are
41
covered.)
42
d.
[(6aR,10aR)
-
9
-
(hydroxymethyl)
-
6,6
-
dimethyl
-
3
-
(2methy
-
43
loctan
-
2
-
yl)
-
6a,7,10,10a
-
tetrahydrobenzo[c]chromen
-
44
1
-
o1)],
also
known
as
6aR
-
trans
-
3
-
(1,1
-
dimethylhep
-
45
tyl)
-
6a,7,10,10a
-
tetrahydro
-
1
-
hydroxy
-
6,6
-
dimethyl
-
6H
-
46
dibenzo[b,d]pyran
-
9
-
methanol
(HU
-
210)
and
its
geometric
47
isomers
(HU211
or
dexanabinol).
48
ii.
The
following
synthetic
drugs:
49
7
a.
Any
compound
structurally
derived
from
(1H
-
indole
-
3
-
1
yl)(cycloalkyl,
cycloalkenyl,
aryl)methanone,
or
(1H
-
in
-
2
dole
-
3
-
yl)(cycloalkyl,
cycloalkenyl,
aryl)methane,
or
3
(1H
-
indole
-
3
-
yl)(cycloalkyl,
cycloalkenyl,
aryl),
methyl
4
or
dimethyl
butanoate,
amino
-
methyl
(or
dimethyl)
-
1
-
oxobu
-
5
tan
-
2
-
yl)
carboxamide
by
substitution
at
the
nitrogen
atoms
6
of
the
indole
ring
or
carboxamide
to
any
extent,
whether
or
7
not
further
substituted
in
or
on
the
indole
ring
to
any
ex
-
8
tent,
whether
or
not
substituted
to
any
extent
in
or
on
the
9
cycloalkyl,
cycloalkenyl,
aryl
ring(s)
(substitution
in
the
10
ring
may
include,
but
is
not
limited
to,
heteroatoms
such
as
1
1
nitrogen,
sulfur
and
oxygen).
12
b.
N
-
(1
-
amino
-
3
-
methyl
-
1
-
oxobutan
-
2
-
yl)
-
1
-
(5
-
fluo
-
13
ropentyl)
-
1
H
-
indazole
-
3
-
carboxamide
(5F
-
AB
-
PINACA).
14
c.
1
-
(1.3
-
benzodioxol
-
5
-
yl)
-
2
-
(ethylamino)
-
pentan
-
1
-
one
15
(N
-
ethylpentylone,
ephylone).
16
d.
1
-
(4
-
cyanobutyl)
-
N
-
(2
-
phenylpropan
-
2
-
yl)
-
1
H
-
inda
-
17
zole
-
3
-
carboxamide
(4
-
cn
-
cumyl
-
BUTINACA).
18
e.
5
-
pentyl
-
2
-
(2
-
phenylpropan
-
2
-
yl)pyrido[4,3
-
b]indol
-
1
-
19
one
(Cumyl
PeGACLONE).
20
f.
Ethyl
2
-
(1
-
(5
-
fluoropentyl)
-
1H
-
indazole
-
3carboxam
-
21
ido)
-
3,3
-
dimethylbutanoate
*
(5F
-
EDMB
-
PINACA).
22
g.
Ethyl
2
-
(1
-
(5
-
fluoropentyl)
-
1H
-
indole
-
3
-
carboxamido)
-
23
3,3
-
dimethylbutanoate
(5F
-
EDMB
-
PICA).
24
h.
(1
-
(4
-
fluorobenzyl)
-
1H
-
indol
-
3
-
yl)(2,2,3,3tetram
-
25
ethylcyclopropyl)methanone
(
FUB
-
144).
26
i.
1
-
(5
-
fluoropentyl)
-
N
-
(2
-
phenylpropan
-
2
-
yl)
-
1H
-
inda
-
27
zole
-
3
-
carboxamide
(5f
-
cumyl
-
pinaca;
SGT
-
25).
28
j.
(1
-
(5
-
fluoropentyl)
-
N
-
(2
-
phenylpropan
-
2
-
yl)
-
1
29
H
-
pyrrolo[2.3
-
B]pyridine
-
3
-
carboxamide(5fcumyl
-
P7AICA).
30
k.
FUB
-
AMB,
MMB
-
FUBINACA
(Methyl
2
-
(1
-
(4
-
fluoroben
-
31
zyl)
-
1H
-
indazole
-
3
-
carboxamido)
-
3
-
methylbutanoate.
32
l.
MMB
-
FUBICA
(Methyl
2
-
(1
-
(4
-
Fluorobenzyl)
-
1H
-
Indole
-
3
-
33
carboxamido)
-
3
-
methyl
butanoate).
34
m.
Methyl
3,3
-
dimethyl
-
2
-
((1
-
(pent
-
4
-
en
-
1
-
yl)
-
1H
-
inda
-
35
zol
-
3
-
yl)formamido)butanoate
(MDMB
-
4EN
-
PINACA).
36
n.
Methyl
2
-
(1
-
(cyclohexylmethyl)
-
1H
-
indole
-
3
-
carboxam
-
37
ido)
-
3
-
methylbutanoate
(MMB
-
CHMICA,
AMB
-
CHMICA).
38
o.
Methyl
2
-
(1
-
(cyclohexylmethyl)
-
1H
-
indole
-
3
-
carboxam
-
39
ido)
-
3,3
-
dimethylbutanoate
(MDMB
-
CHMICA).
40
p.
Methyl
2
-
(1
-
(4
-
fluorobenzyl)
-
1H
-
indazole
-
3
-
carboxam
-
41
ido
-
3,3
-
dimethylbutanoate
(MDMB
-
FUBINACA).
42
q.
Methyl
2
-
[[1
-
(4
-
Fluorobutyl)Indole
-
3
-
Carbonyl]Amino]
-
43
3,3
-
Dimethyl
-
Butanoate
(4F
-
MDMB
-
BUTICA).
44
r.
Methyl
2
-
(1
-
(5
-
fluoropentyl)
-
1H
-
indole
-
3
-
carboxam
-
45
ido)
-
3,3
-
dimethylbutanoate
(5F
-
MDMBPICA).
46
s.
Methyl
2
-
(1
-
(5
-
fluoropentyl)
-
1H
-
indazole
-
3
-
carboxam
-
47
ido)
-
3,3
-
dimethylbutanoate
(5F
-
ADB,
5FMDMB
-
PINACA).
48
t.
Methyl
2
-
(1
-
(5
-
fluoropentyl)
-
1H
-
indazole
-
3
-
carboxam
-
49
ido)
-
3
-
methylbutanoate
(5FAMB).
50
8
u.
N
-
(1
-
Amino
-
3,3
-
dimethyl
-
1
-
oxobutan
-
2
-
yl)
-
1
-
butyl
-
1H
-
1
Indazole
-
3
-
carboxamide
(ADB
-
BUTINACA).
2
v.
N
-
(1
-
amino
-
3,3
-
dimethyl
-
1
-
oxobutan
-
2
-
yl)
-
1
-
(4
-
fluo
-
3
robenzyl)
-
1H
-
indazole
-
3
-
carboxamide
(ADB
-
FUBINACA).
4
w.
N
-
(1
-
Amino
-
3,3
-
dimethyl
-
1
-
oxobutan
-
2
-
yl)
-
1
-
(pent
-
4
-
5
en
-
1
-
yl)
-
1H
-
indazole
-
3
-
carboxamide
(ADB
-
4EN
-
PINACA).
6
x.
N
-
(adamantan
-
1
-
yl)
-
1
-
(4
-
fluorobenzyl)
-
1H
-
indazole
-
3
-
7
carboxamide
(FUB
-
AKB48;
FUB
-
APINACA).
8
y.
N
-
(adamantan
-
1
-
yl)
-
1
-
(5
-
fluoropentyl)
-
1H
-
indazole
-
3
-
9
carboxamide
(5F
-
APINACA,
5F
-
AKB48).
10
z.
N
-
(1
-
amino
-
3
-
methyl
-
1
-
oxobutan
-
2
-
yl)1
-
(Cyclohexyl
-
1
1
methyl)
-
1H
-
indazole
-
3
-
carboxamide
(AB
-
CHMINACA).
12
aa.
Naphthalen
-
1
-
yl
1
-
(5
-
fluoropentyl)
-
1H
-
indole
-
3
-
car
-
13
boxylate
(NM2201;
CBL2201).
14
bb.
Any
compound
structurally
derived
from
3
-
(1
-
naph
-
15
thoyl)pyrrole
by
substitution
at
the
nitrogen
atom
of
the
16
pyrrole
ring
to
any
extent,
whether
or
not
further
sub
-
17
stituted
in
the
pyrrole
ring
to
any
extent,
whether
or
not
18
substituted
in
the
naphthyl
ring
to
any
extent.
19
cc.
Any
compound
structurally
derived
from
1
-
(1
-
naphthyl
-
20
methyl)indene
by
substitution
at
the
3
-
position
of
the
in
-
21
dene
ring
to
any
extent,
whether
or
not
further
substituted
22
in
the
indene
ring
to
any
extent,
whether
or
not
substituted
23
in
the
naphthyl
ring
to
any
extent.
24
dd.
Any
compound
structurally
derived
from
3
-
pheny
-
25
lacetylindole
by
substitution
at
the
nitrogen
atom
of
the
26
indole
ring
to
any
extent,
whether
or
not
further
substi
-
27
tuted
in
the
indole
ring
to
any
extent,
whether
or
not
sub
-
28
stituted
in
the
phenyl
ring
to
any
extent.
29
ee.
Any
compound
structurally
derived
from
2
-
(3
-
hydroxy
-
30
cyclohexyl)phenol
by
substitution
at
the
5
-
position
of
the
31
phenolic
ring
to
any
extent,
whether
or
not
substituted
in
32
the
cyclohexyl
ring
to
any
extent.
33
ff.
Any
compound
structurally
derived
from
3
-
(benzoyl)in
-
34
dole
structure
with
substitution
at
the
nitrogen
atom
of
35
the
indole
ring
to
any
extent,
whether
or
not
further
sub
-
36
stituted
in
the
indole
ring
to
any
extent
and
whether
or
not
37
substituted
in
the
phenyl
ring
to
any
extent.
38
gg.
[2,3
-
dihydro
-
5
-
methyl
-
3
-
(4
-
morpholinyl
-
39
methyl)pyrrolo[1,2,3
-
de]
-
1,4
-
benzoxazin
-
6
-
yl]
-
1
-
40
napthalenylmethanone
(WIN
-
55,212
-
2).
41
hh.
3
-
dimethylheptyl
-
11
-
hydroxyhexahydrocannabinol
(HU
-
42
243).
43
ii.
[(6S,
6aR,
9R,
10aR)
-
9
-
hydroxy
-
6
-
methyl
-
3
-
[(2R)
-
44
5
-
phenylpentan
-
2
-
yl]oxy
-
5,6,6a,7,8,9,10,10a
-
octahy
-
45
drophenanthridin
-
1
-
yl]acetate
(CP
50,5561).
46
(30)
Ethylamine
analog
of
phencyclidine:
N
-
ethyl
-
1
-
phenylcy
-
47
clohexylamine
(1
-
phenylcyclohexyl)
ethylamine;
N
-
(1
-
phenylcy
-
48
clohexyl)
ethylamine,
cyclohexamine,
PCE;
49
9
(31)
Pyrrolidine
analog
of
phencyclidine:
1
-
(phenylcyclohexyl)
-
1
pyrrolidine,
PCPy,
PHP;
2
(32)
Thiophene
analog
of
phencyclidine
1
-
[1
-
(2
-
thienyl)
-
cyclohexyl]
-
3
piperidine,
2
-
thienylanalog
of
phencyclidine,
TPCP,
TCP;
4
(33)
Thiofuranyl
fentanyl;
5
(34)
1
-
[1
-
(2
-
thienyl)
cyclohexyl]
pyrrolidine
another
name:
TCPy;
6
(35)
Spores
or
mycelium
capable
of
producing
mushrooms
that
contain
7
psilocybin
or
psilocin.
8
(e)
Unless
specifically
excepted
or
unless
listed
in
another
schedule,
9
any
material,
compound,
mixture
or
preparation
which
contains
any
quantity
10
of
the
following
substances
having
a
depressant
effect
on
the
central
ner
-
1
1
vous
system,
including
its
salts,
isomers,
and
salts
of
isomers
whenever
the
12
existence
of
such
salts,
isomers,
and
salts
of
isomers
is
possible
within
the
13
specific
chemical
designation:
14
(1)
Clonazolam;
15
(2)
Diclazepam;
16
(3)
Gamma
hydroxybutyric
acid
(some
other
names
include
GHB;
gam
-
17
ma
-
hydroxybutyrate,
4
-
hydroxybutyrate;
4
-
hyroxybutanoic
acid;
sod
-
18
ium
oxybate;
sodium
oxybutyrate);
19
(4)
Etizolam;
20
(5)
Flualprazolam;
21
(6)
Flubromazolam;
22
(7)
Flunitrazepam
(also
known
as
R2,
Rohypnol);
23
(8)
Mecloqualone;
24
(9)
Methaqualone.
25
(f)
Stimulants.
Unless
specifically
excepted
or
unless
listed
in
an
-
26
other
schedule,
any
material,
compound,
mixture,
or
preparation
which
con
-
27
tains
any
quantity
of
the
following
substances
having
a
stimulant
effect
on
28
the
central
nervous
system,
including
its
salts,
isomers,
and
salts
of
iso
-
29
mers:
30
(1)
Amineptine
(7
-
[(10,11
-
dihydro
-
5H
-
dibenzo[a,d]cyclohepten
-
5
-
31
yl)amino]heptanoic
acid);
32
(2)
Aminorex
(some
other
names:
aminoxaphen,
2
-
amino
-
5
-
phenyl
-
2
-
ox
-
33
azoline,
or
4,5
-
dihydro
-
5
-
phenyl
-
2
-
oxazolamine),
4,4'
-
dimethylam
-
34
inorex
(4,4'
-
DMAR;
4,5
-
dihydro
-
4
-
methyl
-
5
-
(4
-
methylphenyl)
-
2
-
oxazo
-
35
lamine)
or
(4,5
-
dihydro
-
5
-
phenyl
-
2
-
oxazolamine);
36
(3)
Cathinone
(some
other
names:
2
-
amino
-
1
-
phenol
-
1
-
propanone,
alp
-
37
ha
-
aminopropiophenone,
2
-
aminopropiophenone
and
norephedrone);
38
(4)
Substituted
cathinones.
Any
compound,
except
bupropion
or
com
-
39
pounds
listed
under
a
different
schedule,
structurally
derived
from
40
2
-
aminopropan
-
1
-
one
by
substitution
at
the
1
-
position
with
either
41
phenyl,
naphthyl
or
thiophene
ring
systems,
whether
or
not
the
compound
42
is
further
modified
in
any
of
the
following
ways:
43
i.
By
substitution
in
the
ring
system
to
any
extent
with
alkyl,
44
alkylenedioxy,
alkoxy,
haloalkyl,
hydroxyl
or
halide
sub
-
45
stituents,
whether
or
not
further
substituted
in
the
ring
system
46
by
one
(1)
or
more
other
univalent
substituents;
47
ii.
By
substitution
at
the
3
-
position
with
an
acyclic
alkyl
sub
-
48
stituent;
49
10
iii.
By
substitution
at
the
2
-
amino
nitrogen
atom
with
alkyl,
1
dialkyl,
benzyl
or
methoxybenzyl
groups,
or
by
inclusion
of
the
2
2
-
amino
nitrogen
atom
in
a
cyclic
structure.
3
(5)
Alpha
-
pyrrolidinoheptaphenone*
(PV8);
4
(6)
Alpha
-
pyrrolidinohexanophenone*
(A
-
PHP);
5
(7)
4
-
chloro
-
alpha
-
pyrrolidinovalerophenone*
(4chloro
-
a
-
pvp);
6
(8)
Eutylone
(1
-
(1,3
-
benzodioxol
-
5
-
yl)
-
2
-
(ethylamino)butan
-
1
-
one);
7
(9)
Fenethylline;
8
(10)
Mesocarb
(N
-
phenyl
-
N'
-
(3
-
(1
-
phenylpropan
-
2
-
yl)
-
1,2,3
-
oxadia
-
9
zol
-
3
-
ium
-
5
-
yl)carbamimidate);
10
(11)
Methcathinone
(some
other
names:
2
-
(methyl
-
amino)
-
propioph
-
1
1
enone,
alpha
-
(methylamino)
-
propiophenone,
N
-
methylcathinone,
AL
-
12
464,
AL
-
422,
AL
-
463
and
UR1423);
13
(12)
Methiopropamine
(N
-
methyl
-
1
-
(thiophen
-
2
-
yl)propan
-
2
-
amine);
14
(13)
(+/
-)cis
-
4
-
methylaminorex
[(+/
-)cis
-
4,5
-
dihydro
-
4
-
meth
-
15
yl
-
5
-
phenyl
-
2
-
oxazolamine];
16
(14)
4
-
methyl
-
alpha
-
ethylaminopentiophenone*
(4
-
MEAP);
17
(15)
4'
-
methyl
-
alpha
-
pyrrolidinohexiophenone*
(MPHP);
18
(16)
2
-
(methylamino)
-
1
-
(3
-
methylphenyl)propan
-
1
-
one
(3
-
MMC);
19
(17)
4
-
methyl
-
1
-
phenyl
-
2
-
(pyrrolidine
-
1
-
yl)pent
-
1
-
one)
(ALPHA
-
20
PIHP);
21
(18)
N
-
benzylpiperazine
(also
known
as:
BZP,
1
-
benzylpiperazine);
22
(19)
N
-
ethylamphetamine;
23
(20)
N
-
ethylhexedrone*;
24
(21)
N,N
-
dimethylamphetamine
(also
known
as:
N,N
-
alpha
-
trimethyl
-
25
benzeneethanamine).
26
(g)
Unless
specifically
excepted
or
unless
listed
in
another
schedule,
27
any
alkaloids
found
in
or
derived
from
Mitragyna
speciosa,
including
syn
-
28
thetic
alkaloids,
homologs,
analogs,
isomers,
esters,
ethers,
salts,
and
29
salts
of
isomers,
esters,
and
ethers,
when
the
existence
of
the
isomers,
es
-
30
ters,
ethers,
and
salts
is
possible
within
the
specific
chemical
designa
-
31
tion.
32
SECTION
2.
An
emergency
existing
therefor,
which
emergency
is
hereby
33
declared
to
exist,
this
act
shall
be
in
full
force
and
effect
on
and
after
34
July
1,
2026.
35